Trading FDA, Clinical Trial Binary Events: New Features at mikehavRx.com

Several new free and premium features have been added to the mikehavRx.com Index Updates service and website to provide investors and traders with time-saving information to make their own investing decisions. The service is provided in the form of PDF files located at the subscriber home page (in the format illustrated above this paragraph) that can be accessed upon successful log-in. Currently, 23 PDFs are available to premium subscribers, including 17 files for each of the passively managed stock index components and six reports for the actively managed Regulatory Catalyst Index.

BioRunUp.com is now collaborating with mikehavRx.com to provide investors with free articles, select binary event data, and binary event investing strategies. The subscriber home page and calendars page now includes integrated news feeds, twitter feeds, and RSS feeds for mikehavRx.com, BioRunUp.com, FDA / clinical trial news, stock market news, bio-pharmaceutical industry news, and medical news. Other recently updated pages at mikehavRx.com include the frequently asked questions (FAQS) and videos page for additional resources and links.

The Regulatory Catalyst Index reports are sorted by company name, stock ticker, catalyst date, stock price, and the date of most recent update for each entry and are updated on regular stock market trading days between 6-8pm (ET) along with a new daily stock watch list report that includes up to 50 companies with the company name, stock ticker, price at regular market close, percentage change, 52-week high / low, and comments / strategy.

Private companies are tracked by the daily Regulatory Catalyst Index update reports due to their potential impact on competing products of public-traded companies, potential partnerships / acquisitions of these companies, the improving initial public offering (IPO) market, and to expand beyond the current global, public-traded company database of FDA and clinical trial developments.

The actively managed HavRx Regulatory Catalyst Index tracks the performance of select companies which meet any of the following requirements: (1) pending new drug, biological agent, medical device, or diagnostic product applications at the FDA; (2) pending pivotal clinical trial results that are designed to support a new filing or resubmission for FDA marketing clearance; and (3) pending early stage clinical study results. Categories (1) and (2) will comprise two-third (67%) or greater of all index components while companies with pending early stage clinical trial results will comprise one-third (33%) or less of all index components.

Regulatory Catalyst Index Update Report statistics include the following:

- 577 total entries to track select pending binary event data (FDA decisions, clinical trials)

- 375 companies tracked, including 118 active index components and 31 private companies

- 250 companies under $10 per share, 200 companies under $5 per share

In addition, a Google Calendar is available to subscribers for upcoming quarterly conference calls, presentations, and related events for Regulatory Catalyst Index active components and watch list stocks to complement the five daily update reports and binary event tracking data. A second calendar has also been added to track these events for the 17 passively managed indexes.

www.mikehavRx.com is your prescription for stock index investing updates focused on the healthcare sector, medical innovation, and pending binary events such as FDA decisions and clinical trials. The actively managed HavRx Regulatory Catalyst Index update report is currently tracking 575 entries and 374 companies (including approximately 200 stocks trading under $5 per share and 31 private companies). Promo codes (50% discount) are available for college students, investment clubs, and subscribers to my previous FDA Calendar or similar services.